The Cardiovascular Risk of White-Coat Hypertension
Language English Country United States Media print
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
27810041
DOI
10.1016/j.jacc.2016.08.035
PII: S0735-1097(16)35148-8
Knihovny.cz E-resources
- Keywords
- ambulatory blood pressure monitoring, cardiovascular disease, epidemiology, white-coat effect,
- MeSH
- Blood Pressure Monitoring, Ambulatory methods MeSH
- Global Health MeSH
- Risk Assessment methods MeSH
- Incidence MeSH
- Blood Pressure physiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Forecasting * MeSH
- Risk Factors MeSH
- White Coat Hypertension epidemiology physiopathology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The role of white-coat hypertension (WCH) and the white-coat-effect (WCE) in development of cardiovascular disease (CVD) risk remains poorly understood. OBJECTIVES: Using data from the population-based, 11-cohort IDACO (International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes), this study compared daytime ambulatory blood pressure monitoring with conventional blood pressure measurements in 653 untreated subjects with WCH and 653 normotensive control subjects. METHODS: European Society Hypertension guidelines were used as a 5-stage risk score. Low risk was defined as 0 to 2 risk factors, and high risk was defined as ≥3 to 5 risk factors, diabetes, and/or history of prior CVD events. Age- and cohort-matching was done between 653 untreated subjects with WCH and 653 normotensive control subjects. RESULTS: In a stepwise linear regression model, systolic WCE increased by 3.8 mm Hg (95% confidence interval [CI]: 3.1 to 4.6 mm Hg) per 10-year increase in age, and was similar in low- and high-risk subjects with or without prior CVD events. Over a median 10.6-year follow-up, incidence of new CVD events was higher in 159 high-risk subjects with WCH compared with 159 cohort- and age-matched high-risk normotensive subjects (adjusted hazard ratio [HR]: 2.06; 95% CI: 1.10 to 3.84; p = 0.023). The HR was not significant for 494 participants with low-risk WCH and age-matched low-risk normotensive subjects. Subgroup analysis by age showed that an association between WCH and incident CVD events is limited to older (age ≥60 years) high-risk WCH subjects; the adjusted HR was 2.19 (95% CI: 1.09 to 4.37; p = 0.027) in the older high-risk group and 0.88 (95% CI: 0.51 to 1.53; p = 0.66) in the older low-risk group (p for interaction = 0.044). CONCLUSIONS: WCE size is related to aging, not to CVD risk. CVD risk in most persons with WCH is comparable to age- and risk-adjusted normotensive control subjects.
Asociación Española Primera de Socorros Mutuos Montevideo Uruguay
Cambridge University Hospitals Addenbrook's Hospital Cambridge United Kingdom
Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin Ireland
Department of Medicine Glostrup Hospital University of Copenhagen Copenhagen Denmark
Department of Medicine University of Padua Padua Italy
Faculty of Medicine Charles University Pilsen Czech Republic
Institute of Internal Medicine Novosibirsk Russian Federation
Steno Diabetes Center Gentofte and Research Center for Prevention and Health Gentofte Denmark
Tohoku University Graduate School of Pharmaceutical Science and Medicine Sendai Japan
Tohoku University Graduate School of Pharmaceutical Sciences Sendai Japan
References provided by Crossref.org